Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study. (2022)
Attributed to:
Epigenetic Epidemiology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7554/elife.75374
PubMed Identifier: 35346416
Publication URI: http://europepmc.org/abstract/MED/35346416
Type: Journal Article/Review
Volume: 11
Parent Publication: eLife
ISSN: 2050-084X